Invivyd (IVVD) EBIT (QoQ) (2021 - 2025)
Invivyd (IVVD) EBIT (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Invivyd | 103.90 Mn | -122.79 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.90% |
| Sep 30, 2025 | 26.81% |
| Jun 30, 2025 | 11.00% |
| Mar 31, 2025 | 12.00% |
| Dec 31, 2024 | 69.14% |
| Sep 30, 2024 | -26.53% |
| Jun 30, 2024 | -6.85% |
| Mar 31, 2024 | 39.95% |
| Dec 31, 2023 | -78.24% |
| Sep 30, 2023 | 20.07% |
| Jun 30, 2023 | -37.89% |
| Mar 31, 2023 | 18.96% |
| Dec 31, 2022 | -1.86% |
| Sep 30, 2022 | 8.54% |
| Jun 30, 2022 | 48.63% |
| Mar 31, 2022 | -21.24% |
| Dec 31, 2021 | -37.53% |
| Sep 30, 2021 | -35.19% |
| Jun 30, 2021 | -15.45% |